Bayer welcomes the U.S. Supreme Court decision to review Durnell case in the Roundup litigation
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Fresh Phase 1b/2a data highlight the strength of the iberdomide + daratumumab + dexamethasone combination in transplant-deferred or ineligible NDMM
At the heart of the showdown is a deep split among federal circuit courts over whether federal law overrides state failure-to-warn claims in Roundup personal-injury suits
In 2024, 59 countries reported large or disruptive measles outbreaks – nearly triple the number reported in 2021 and the highest since the onset of the COVID-19 pandemic
India's pharmaceutical sector is rapidly shifting from a generics-led foundation to an innovation-driven ecosystem
A key highlight will be Brenntag’s qualified amino acids portfolio
Adzynma, approved for both adults and children with cTTP, is a recombinant enzyme therapy designed to replace the deficient ADAMTS13 enzyme
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Subscribe To Our Newsletter & Stay Updated